Adults over 50 with high blood pressure and cardiovascular risk but no diabetes aiming for systolic pressure under 120 instead of under 140 cut heart failure risk by 38% relative.
See the scientific wording
In adults aged 50 years or older with hypertension and increased cardiovascular risk but without diabetes, targeting a systolic blood pressure below 120 mm Hg, compared with targeting a systolic blood pressure below 140 mm Hg, reduces the relative risk of heart failure by 38% (relative risk reduction of 38%; absolute risk reduction not reported).
Supported
Randomized trials3 of 3 parts have evidence behind them.
Supported
3 of 3 parts have evidence behind them.
Parts of this claim
Targeting systolic blood pressure below 120 mm Hg reduces relative risk of heart failure compared with targeting systolic blood pressure below 140 mm Hg.
Supported1 studyThe reduction in relative risk of heart failure is 38%.
Supported1 studyThe reduction in relative risk of heart failure occurs in adults aged 50 years or older with hypertension and increased cardiovascular risk but without diabetes.
Supported1 study
Evidence is judged against each part on its own, so a study that tests one part never counts as a verdict on the whole claim.
What the research says
1 study reviewedSupporting (1)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Randomized Controlled TrialHuman2015
In a large trial, people with high blood pressure and higher heart risk who aimed for under 120 had a 38% lower chance of heart failure than those aiming for under 140, and the study did not report the absolute number of cases prevented.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When blood pressure is kept very low, the heart pumps against less resistance. This lowers the force the heart muscle must generate with each beat. Medicines that lower blood pressure also block stress hormones and remove extra fluid. Together, these actions stop the heart muscle from thickening and stiffening. The heart stays relaxed and fills properly, so heart failure does not develop.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Adults over 50 with high blood pressure and cardiovascular risk but no diabetes aiming for systolic pressure under 120 instead of under 140 cut heart failure risk by 38% relative.
Mechanism
1 studyKeeping blood pressure very low reduces the force the heart must push against. It also blocks stress hormones and removes extra fluid. These changes stop the heart from getting thick and stiff, so it can fill and pump normally. This prevents heart failure.
When blood pressure is kept very low, the heart pumps against less resistance. This lowers the force the heart muscle must generate with each beat. Medicines that lower blood pressure also block stress hormones and remove extra fluid. Together, these actions stop the heart muscle from thickening and stiffening. The heart stays relaxed and fills properly, so heart failure does not develop.
Intensive blood pressure treatment achieves a systolic pressure below 120 mm Hg by using a greater number of antihypertensive medications, including thiazide-type diuretics, loop diuretics, ACE inhibitors, angiotensin-receptor blockers, beta-blockers, and calcium-channel blockers.
Lower systolic pressure reduces the resistance the left ventricle must pump against, decreasing left ventricular wall stress and cardiac workload.
Blockade of the renin-angiotensin-aldosterone system and sympathetic nervous system decreases neurohormonal activation, which reduces maladaptive cardiac hypertrophy, fibrosis, and chamber dilation.
Diuretics reduce plasma volume and venous return, lowering preload and decreasing pulmonary and systemic congestion.
Reduced afterload, preload, and neurohormonal stress preserve diastolic and systolic cardiac function, preventing the development of heart failure.
Evidence from Studies
Supporting (1)
Community contributions welcome
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
In a large trial, people with high blood pressure and higher heart risk who aimed for under 120 had a 38% lower chance of heart failure than those aiming for under 140, and the study did not report the absolute number of cases prevented.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Meta-Analysis of Randomized Trials of Systolic Blood Pressure Target Below 120 vs Below 140 mm Hg for Heart Failure Prevention
Systematic search of randomized controlled trials in adults aged 50 years or older with hypertension and increased cardiovascular risk but without diabetes, comparing systolic blood pressure target below 120 mm Hg versus below 140 mm Hg, with heart failure as the outcome; meta-analysis with random effects, heterogeneity assessment, and absolute risk difference calculation over at least 3 years of follow-up.
Randomized Trial of Intensive Systolic Blood Pressure Target Below 120 mm Hg vs Below 140 mm Hg for Heart Failure in High-Risk Older Adults
Multicenter randomized controlled trial enrolling adults aged 50 years or older with hypertension and increased cardiovascular risk but without diabetes; intervention arm targets systolic blood pressure below 120 mm Hg and comparator targets below 140 mm Hg; primary outcome is incident heart failure; follow-up of 3 to 5 years with blinded outcome adjudication and measurement of both relative and absolute risk reductions.
Prospective Cohort Study of Achieved Systolic Blood Pressure Below 120 mm Hg and Incident Heart Failure in Older Hypertensive Adults
Prospective cohort of adults aged 50 years or older with hypertension and increased cardiovascular risk but without diabetes, categorized by achieved systolic blood pressure below 120 mm Hg versus below 140 mm Hg, followed for incident heart failure with adjustment for confounders and repeated blood pressure measurements.
Case-Control Study of Prior Intensive Systolic Blood Pressure Target and Heart Failure Hospitalization
Case-control study identifying adults aged 50 years or older with incident heart failure and matched controls without heart failure; exposure is documented systolic blood pressure target below 120 mm Hg versus below 140 mm Hg; adjusts for cardiovascular risk factors and medication use.
Cross-Sectional Analysis of Systolic Blood Pressure Target and Heart Failure Prevalence in Older Hypertensive Adults
Cross-sectional survey or registry analysis of adults aged 50 years or older with hypertension and increased cardiovascular risk but without diabetes, measuring current systolic blood pressure target and prevalent heart failure, comparing prevalence by target below 120 mm Hg versus below 140 mm Hg.